BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23579946)

  • 1. Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.
    Miedema KG; Winter RH; Ammann RA; Droz S; Spanjaard L; de Bont ES; Kamps WA; van de Wetering MD; Tissing WJ
    Support Care Cancer; 2013 Sep; 21(9):2417-26. PubMed ID: 23579946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteremia in febrile cancer patients in Uganda.
    Lubwama M; Phipps W; Najjuka CF; Kajumbula H; Ddungu H; Kambugu JB; Bwanga F
    BMC Res Notes; 2019 Jul; 12(1):464. PubMed ID: 31362783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergence of Carbapenem resistant Gram negative and vancomycin resistant Gram positive organisms in bacteremic isolates of febrile neutropenic patients: a descriptive study.
    Irfan S; Idrees F; Mehraj V; Habib F; Adil S; Hasan R
    BMC Infect Dis; 2008 Jun; 8():80. PubMed ID: 18541017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic susceptibility of Gram-negatives isolated from bacteremia in children with cancer. Implications for empirical therapy of febrile neutropenia.
    Castagnola E; Caviglia I; Pescetto L; Bagnasco F; Haupt R; Bandettini R
    Future Microbiol; 2015; 10(3):357-64. PubMed ID: 25812459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microbiological characteristics of pathogens causing bacteremia among hospitalized pediatric oncology patients with fever and neutropenia].
    Leibson T; Ben-Shimol S; Hazan G; Fruchtman Y; Kapelushnik J; Greenberg D
    Harefuah; 2012 Oct; 151(10):592-6, 603-4. PubMed ID: 23316669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance.
    Lee NH; Kang JM; Lee JW; Huh HJ; Lee NY; Yoo KH; Sung KW; Koo HH; Kim YJ
    Pediatr Infect Dis J; 2020 Oct; 39(10):931-936. PubMed ID: 32453199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Febrile Neutropenia: Change in Etiology of Bacteremia, Empiric Choice of Therapy and Clinical Outcomes.
    Alali M; David MZ; Danziger-Isakov LA; Elmuti L; Bhagat PH; Bartlett AH
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e445-e451. PubMed ID: 32404688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
    Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive bacterial infections in a pediatric oncology unit in a tertiary care center.
    Trehan A; Totadri S; Gautam V; Bansal D; Ray P
    Indian J Cancer; 2014; 51(4):428-31. PubMed ID: 26842149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients--risk factors and outcomes.
    Haeusler GM; Mechinaud F; Daley AJ; Starr M; Shann F; Connell TG; Bryant PA; Donath S; Curtis N
    Pediatr Infect Dis J; 2013 Jul; 32(7):723-6. PubMed ID: 23838774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current time-to-positivity of blood cultures in febrile neutropenia: a tool to be used in stewardship de-escalation strategies.
    Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Del Río A; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2019 Apr; 25(4):447-453. PubMed ID: 30096417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in paediatric and adult bloodstream infections at a Ghanaian referral hospital: a retrospective study.
    Obeng-Nkrumah N; Labi AK; Addison NO; Labi JE; Awuah-Mensah G
    Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):49. PubMed ID: 27539221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D; Moser A; Yagupsky P; Peled N; Hofman Y; Kapelushnik J; Leibovitz E
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group.
    Averbuch D; Tridello G; Hoek J; Mikulska M; Akan H; Yanez San Segundo L; Pabst T; Özçelik T; Klyasova G; Donnini I; Wu D; Gülbas Z; Zuckerman T; Botelho de Sousa A; Beguin Y; Xhaard A; Bachy E; Ljungman P; de la Camara R; Rascon J; Ruiz Camps I; Vitek A; Patriarca F; Cudillo L; Vrhovac R; Shaw PJ; Wolfs T; O'Brien T; Avni B; Silling G; Al Sabty F; Graphakos S; Sankelo M; Sengeloev H; Pillai S; Matthes S; Melanthiou F; Iacobelli S; Styczynski J; Engelhard D; Cesaro S
    Clin Infect Dis; 2017 Nov; 65(11):1819-1828. PubMed ID: 29020364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of Common Bacterial and Fungal Pathogens in Children with Hematological Malignancies during Febrile Neutropenia: Single Center Egyptian Study.
    Hagag AA; Hassan SM; Elgamasy MA; Afifi IK
    Infect Disord Drug Targets; 2016; 16(1):54-62. PubMed ID: 26715443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of an antimicrobial cycling strategy for febrile neutropenia in a haematology unit.
    Kontopidou FV; Antoniadou A; Tsirigotis P; Venetis E; Polemis M; Patrinos S; Giamarellou H
    J Chemother; 2013 Oct; 25(5):279-85. PubMed ID: 24070135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia.
    Jones RN
    Clin Infect Dis; 1999 Sep; 29(3):495-502. PubMed ID: 10530435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.